Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.

about

Scale-up of Kenya's national HIV viral load program: Findings and lessons learned.HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa

P2860

Q47555214-C6D2465F-68B3-405E-A25B-047CBBCA8541 Q56938270-22F01A17-7966-4BDB-A790-C0C30465B79B

P2860

Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.

Item

http://www.wikidata.org/entity/Q40548877

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Differences in virologic and i ...... infected infants and children.

@en

type

Item

label

Differences in virologic and i ...... infected infants and children.

@en

prefLabel

Differences in virologic and i ...... infected infants and children.

@en

P1476

Differences in virologic and i ...... infected infants and children.

@en

P2093

Agnes Langat

http://www.w3.org/2001/XMLSchema#string

Ali Rowhani-Rahbar

http://www.w3.org/2001/XMLSchema#string

Hellen M Okinyi

http://www.w3.org/2001/XMLSchema#string

James P Hughes

http://www.w3.org/2001/XMLSchema#string

Jennifer A Slyker

http://www.w3.org/2001/XMLSchema#string

Kristjana H Ásbjörnsdóttir

http://www.w3.org/2001/XMLSchema#string

P2860

Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?

Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study.

HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy

Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS

Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.

Early antiretroviral therapy and mortality among HIV-infected infants

Pediatric adherence to HIV antiretroviral therapy

Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.

Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study

P304

2835-2843

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000001244

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Grace John-Stewart

Kristjana Ásbjörnsdóttir

Elizabeth Maleche-Obimbo

P577

2016-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27603293

http://www.w3.org/2001/XMLSchema#string

P921

virology

P932

5101154

http://www.w3.org/2001/XMLSchema#string

Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.

about

P2860

P2860

Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932